High Helicobacter pylori cure rate with sitafloxacin-based triple therapy.

@article{Sugimoto2015HighHP,
  title={High Helicobacter pylori cure rate with sitafloxacin-based triple therapy.},
  author={M Sugimoto and Shu Sahara and Hiroyuki Ichikawa and Takuma Kagami and Takahiro Uotani and T Furuta},
  journal={Alimentary pharmacology & therapeutics},
  year={2015},
  volume={42 4},
  pages={477-83}
}
BACKGROUND Bacterial resistance of Helicobacter pylori to antibiotics is increasing and it often leads to failure of antibiotic treatment. A new sitafloxacin-based triple therapy was developed to counter this situation; the fluoroquinolone sitafloxacin has a low minimum inhibitory concentration for H. pylori. AIM To investigate the efficacy in Japanese patients of sitafloxacin-based triple therapy and document its efficacy in relation to anti-microbial susceptibility. METHODS We… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 12 times. VIEW TWEETS